ImmunoPET imaging of human CD8+ T cells with novel 68Ga-labeled nanobody companion diagnostic agents
Abstract Background Although immunotherapy has revolutionized treatment strategies for some types of cancers, most patients failed to respond or obtain long-term benefit. Tumor-infiltrating CD8+ T lymphocytes are closely related to the treatment outcome and prognosis of patients. Therefore, noninvas...
Main Authors: | Haitao Zhao, Chao Wang, Yanling Yang, Yan Sun, Weijun Wei, Cheng Wang, Liangrong Wan, Cheng Zhu, Lianghua Li, Gang Huang, Jianjun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-00785-9 |
Similar Items
-
ImmunoPET in Multiple Myeloma—What? So What? Now What?
by: Clément Bailly, et al.
Published: (2020-06-01) -
Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
by: Weijun Wei, et al.
Published: (2020-07-01) -
Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm
by: Julian Kirchner, et al.
Published: (2021-01-01) -
Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124
by: Krishan Kumar, et al.
Published: (2021-01-01) -
Next-Generation Molecular Imaging of Thyroid Cancer
by: Yuchen Jin, et al.
Published: (2021-06-01)